08 / April / 2026 “Without suitable comparison between groups, there is no way of proving the efficacy of a new drug” Cardiologist and researcher at Einstein Hospital Israelita explains the role of randomized clinical trials and the risks of social pressure on clinical research By Moura Leite Netto
12 / March / 2026 Clinical research from the inside: science, careers, and impact on health A hybrid field within healthcare, clinical research presents challenges for which ethics, regulation, and protocols are essential to transforming science into evidence and ensuring patient safety By Patricia Monteiro Quintino
19 / January / 2026 Medical career: planning transitions between clinical practice, research, and industry Drawing on her experience in endocrinology, clinical research, and pharmacovigilance, Sonia Mansoldo Dainesi advises physicians considering career transitions. By Gabriela Monteiro
15 / May / 2025 Otavio Berwanger: “We need to increase the efficiency of randomized clinical trials” Executive director of the George Institute for Global Health UK and chair in Clinical Trials at Imperial College London advocates for more efficient, innovative, and representative clinical trials based on pragmatic designs, digital technology, AI applications, routinely collected data, and patient and public involvement participation By Gilberto Stam
29 / January / 2025 AI could increase accuracy in clinical trials Study reveals that GPT-4 models outperform experts at selecting patients with heart failure, optimizing inclusion in clinical trials, and reducing operational costs By Moura Leite Netto
14 / January / 2025 To reduce costs and increase diversity in clinical studies A US regulatory agency advocates analyzing treatment efficacy by combining observational studies with targeted data collection By Editorial staff
19 / December / 2024 Fighting Alzheimer’s with science and empathy Brazilian biologist is leading research that seeks to develop a simple, less invasive method for diagnosing the disease that affects her mother By Letícia Naísa
18 / December / 2024 Collaborative effort to unlock Down syndrome Focusing on personalized medicine, Argentine biologist Joaquin Espinosa outlines how recent advancements in research can help predict risks and enhance the quality of life for individuals with Down syndrome By Moura Leite Netto
08 / November / 2024 When should medications be deprescribed? Physicians should suspend prescription of cardiovascular medications when there could be potential harm or if there are better alternatives, warn researchers By Editorial staff
17 / September / 2024 New uses for existing drugs International programs weigh up costs and benefits in the search for new forms of treatment with existing drugs By Editorial staff
